tiprankstipranks
Blueprint Medicines (BPMC)
NASDAQ:BPMC
Holding BPMC?
Track your performance easily

Blueprint Medicines (BPMC) Similar Stocks

553 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Blueprint Medicines
$110.05
$6.60B
35.78%
9 Buy
5 Hold
0 Sell
Moderate Buy
Alnylam Pharma
$246.27
$32.14B
33.82%
16 Buy
5 Hold
1 Sell
Moderate Buy
FibroGen
$0.57
$58.39M
-24.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
Revolution Medicines
$40.29
$7.28B
49.61%
14 Buy
0 Hold
0 Sell
Strong Buy
RegenXBio
$7.37
$354.25M
-46.24%
10 Buy
0 Hold
0 Sell
Strong Buy
Kura Oncology
$7.26
$558.34M
-50.58%
13 Buy
2 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$118.00
$11.18B
98.02
2.04%
18 Buy
0 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
BPMC
Blueprint Medicines
110.05
27.03
32.56%
ALNY
Alnylam Pharma
246.27
62.35
33.90%
FGEN
FibroGen
0.57
-0.31
-35.23%
RVMD
Revolution Medicines
40.29
12.75
46.30%
RGNX
RegenXBio
7.37
-6.83
-48.10%
KURA
Kura Oncology
7.26
-6.74
-48.14%
SRPT
Sarepta Therapeutics
118.00
-3.05
-2.52%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis